AbbVie (NYSE:ABBV) continues to navigate the challenges of Humira's loss of exclusivity while leveraging its diverse portfolio and robust pipeline to drive future growth. With a gross profit margin of ...
7hon MSN
AbbVie (ABBV) is expected to beat Q4 earnings estimates with strong performance from key products, including Skyrizi and ...
Wells Fargo analyst Mohit Bansal downgraded Vertex Pharmaceuticals (VRTX) to Equal Weight from Overweight with an unchanged price target of ...
True leadership is about putting others first,” said Jason B. Daly, chief legal officer of Amneal Pharmaceuticals.
Merck & Co. Inc. 2.50% $241.71B ...
Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...
Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,02,211.39 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback